Loading data
ANRONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | 45.62 m USD | 47 m USD | 30.29 m USD |
| Operating profit | -66.36 m USD | -68.61 m USD | -37.81 m USD |
| Income tax expense | 0 USD | — | — |
| Net income (reported basis) | -63.24 m USD | -61.43 m USD | -36.31 m USD |
| Basic earnings per share | -2.19 USD/share | -2.5 USD/share | -9.73 USD/share |
| Diluted earnings per share | -2.19 USD/share | -2.5 USD/share | -9.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.